Adicet Bio Stock Performance
| ACET Stock | USD 8.32 0.38 4.37% |
The firm shows a Beta (market volatility) of 0.92, which signifies possible diversification benefits within a given portfolio. Adicet Bio returns are very sensitive to returns on the market. As the market goes up or down, Adicet Bio is expected to follow. At this point, Adicet Bio has a negative expected return of -0.45%. Please make sure to confirm Adicet Bio's total risk alpha, as well as the relationship between the rate of daily change and relative strength index , to decide if Adicet Bio performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
Weakest
Weak | Strong |
Over the last 90 days Adicet Bio has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's technical and fundamental indicators remain comparatively stable which may send shares a bit higher in February 2026. The newest uproar may also be a sign of mid-term up-swing for the firm private investors. ...more
Actual Historical Performance (%)
One Day Return 3.08 | Five Day Return 6.62 | Year To Date Return (1.36) | Ten Year Return (99.54) | All Time Return (99.54) |
Last Split Factor 1:16 | Dividend Date 2020-09-16 | Last Split Date 2025-12-30 |
1 | How institutional buying supports Adicet Bio Inc. stock - 2025 Price Momentum AI Forecasted Entry and Exit Points - newser.com | 11/14/2025 |
2 | Why Adicet Bio Inc. stock is a strong analyst pick - Take Profit Low Drawdown Investment Ideas - newser.com | 11/17/2025 |
3 | Disposition of 26400 shares by Gordon Carl L of Adicet Bio at 2.14 subject to Rule 16b-3 | 11/25/2025 |
4 | Adicet Bio Reports Inducement Grant under Nasdaq Listing Rule 5635 | 11/28/2025 |
5 | Adicet Bio, Inc. Given Average Rating of Moderate Buy by Analysts - MarketBeat | 12/17/2025 |
6 | Adicet Bio Announces Reverse Stock Split | 12/26/2025 |
| Begin Period Cash Flow | 159.7 M | |
| Total Cashflows From Investing Activities | -119.2 M |
Adicet Bio Relative Risk vs. Return Landscape
If you would invest 1,201 in Adicet Bio on October 29, 2025 and sell it today you would lose (331.00) from holding Adicet Bio or give up 27.56% of portfolio value over 90 days. Adicet Bio is currently does not generate positive expected returns and assumes 4.1302% risk (volatility on return distribution) over the 90 days horizon. In different words, 37% of stocks are less volatile than Adicet, and 99% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Adicet Bio Target Price Odds to finish over Current Price
The tendency of Adicet Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 8.32 | 90 days | 8.32 | about 73.53 |
Based on a normal probability distribution, the odds of Adicet Bio to move above the current price in 90 days from now is about 73.53 (This Adicet Bio probability density function shows the probability of Adicet Stock to fall within a particular range of prices over 90 days) .
Given the investment horizon of 90 days Adicet Bio has a beta of 0.92. This suggests Adicet Bio market returns are related to returns on the market. As the market goes up or down, Adicet Bio is expected to follow. Additionally Adicet Bio has a negative alpha, implying that the risk taken by holding this instrument is not justified. The company is significantly underperforming the Dow Jones Industrial. Adicet Bio Price Density |
| Price |
Predictive Modules for Adicet Bio
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Adicet Bio. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Adicet Bio's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Adicet Bio Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Adicet Bio is not an exception. The market had few large corrections towards the Adicet Bio's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Adicet Bio, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Adicet Bio within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | -0.78 | |
β | Beta against Dow Jones | 0.92 | |
σ | Overall volatility | 1.94 | |
Ir | Information ratio | -0.18 |
Adicet Bio Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Adicet Bio for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Adicet Bio can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Adicet Bio generated a negative expected return over the last 90 days | |
| Adicet Bio has high historical volatility and very poor performance | |
| Adicet Bio has high likelihood to experience some financial distress in the next 2 years | |
| Net Loss for the year was (117.12 M) with profit before overhead, payroll, taxes, and interest of 24.99 M. | |
| Adicet Bio currently holds about 260.64 M in cash with (92.38 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 6.11. | |
| Adicet Bio has a poor financial position based on the latest SEC disclosures |
Adicet Bio Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Adicet Stock often depends not only on the future outlook of the current and potential Adicet Bio's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Adicet Bio's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 5.5 M | |
| Cash And Short Term Investments | 176.3 M |
Adicet Bio Fundamentals Growth
Adicet Stock prices reflect investors' perceptions of the future prospects and financial health of Adicet Bio, and Adicet Bio fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Adicet Stock performance.
| Return On Equity | -0.72 | ||||
| Return On Asset | -0.39 | ||||
| Current Valuation | (6.54 M) | ||||
| Shares Outstanding | 9.6 M | ||||
| Price To Earning | 36.84 X | ||||
| Price To Book | 0.74 X | ||||
| Price To Sales | 9.72 X | ||||
| Gross Profit | 24.99 M | ||||
| EBITDA | (110.65 M) | ||||
| Net Income | (117.12 M) | ||||
| Cash And Equivalents | 260.64 M | ||||
| Cash Per Share | 6.11 X | ||||
| Total Debt | 17.23 M | ||||
| Debt To Equity | 0.08 % | ||||
| Current Ratio | 16.10 X | ||||
| Book Value Per Share | 19.04 X | ||||
| Cash Flow From Operations | (92.38 M) | ||||
| Earnings Per Share | (20.00) X | ||||
| Market Capitalization | 83.52 M | ||||
| Total Asset | 220.22 M | ||||
| Retained Earnings | (497.89 M) | ||||
| Working Capital | 160.74 M | ||||
| Current Asset | 352.66 M | ||||
| Current Liabilities | 98.91 M | ||||
About Adicet Bio Performance
Assessing Adicet Bio's fundamental ratios provides investors with valuable insights into Adicet Bio's financial health and overall profitability. This information is crucial for making informed investment decisions. A high ROA would indicate that the Adicet Bio is effectively leveraging its assets and equity to generate significant profits, making it an appealing investment. Conversely, low Return on Assets could signal underlying management issues in assets and equity, indicating a necessity for operational refinements. Please also refer to our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 78.32 | 68.13 | |
| Return On Tangible Assets | (0.61) | (0.58) | |
| Return On Capital Employed | (0.73) | (0.69) | |
| Return On Assets | (0.61) | (0.58) | |
| Return On Equity | (0.72) | (0.69) |
Things to note about Adicet Bio performance evaluation
Checking the ongoing alerts about Adicet Bio for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Adicet Bio help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Adicet Bio generated a negative expected return over the last 90 days | |
| Adicet Bio has high historical volatility and very poor performance | |
| Adicet Bio has high likelihood to experience some financial distress in the next 2 years | |
| Net Loss for the year was (117.12 M) with profit before overhead, payroll, taxes, and interest of 24.99 M. | |
| Adicet Bio currently holds about 260.64 M in cash with (92.38 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 6.11. | |
| Adicet Bio has a poor financial position based on the latest SEC disclosures |
- Analyzing Adicet Bio's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Adicet Bio's stock is overvalued or undervalued compared to its peers.
- Examining Adicet Bio's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Adicet Bio's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Adicet Bio's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Adicet Bio's stock. These opinions can provide insight into Adicet Bio's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Adicet Stock Analysis
When running Adicet Bio's price analysis, check to measure Adicet Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Adicet Bio is operating at the current time. Most of Adicet Bio's value examination focuses on studying past and present price action to predict the probability of Adicet Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Adicet Bio's price. Additionally, you may evaluate how the addition of Adicet Bio to your portfolios can decrease your overall portfolio volatility.